This is an editorial pick, not a submission. It’s Talmyn’s own research into a small brand making a deliberately narrow bet, published as part of our ongoing Talmyn Startup 100 coverage.

SupplementMe is a UK-based online supplement business selling a small, fixed range: a Vitamin D3 gummy, a Vegan Daily Multivitamin, a Probiotic at 10 billion CFU, an Acerola Vitamin C Complex, and an Ashwagandha gummy. That’s the entire catalog. Every product on the site is manufactured to the UK’s GMP (Good Manufacturing Practice) standard, carries full ingredient labeling, and the range offers vegan and vegetarian options across the board rather than as an exception on one or two items.

Why this made the list, with real limits stated plainly

In fairness, a five-product catalog and GMP manufacturing are not, on their own, a rare structural decision. Plenty of small supplement brands make the same claims, and Talmyn has not been able to independently verify manufacturing specifics beyond what SupplementMe states on its own site. The company’s own materials don’t name a founder or tell an origin story: the name Tarik Azirar appears only in SupplementMe’s submission to Talmyn, not on the site itself, so Talmyn is not treating that as a verified public fact here. There’s also no independently verifiable traction data available: no funding history, no press coverage Talmyn could locate, and no distribution beyond direct-to-consumer sales. The company cites a 4.8-out-of-5 rating from more than 120 reviews, but that figure comes from SupplementMe’s own site, not a third-party review platform Talmyn could check directly.

What is a genuine, describable decision is the restraint itself. Rather than the sprawling 30-to-50-SKU catalogs common among UK supplement DTC brands, SupplementMe stayed at five products and applied the same manufacturing and labeling standard to all of them. That’s a narrower bet than most competitors are willing to make, and it’s the specific, checkable thing Talmyn can point to here, not a claim about scale or funding this company hasn’t reached yet.

Talmyn’s Startup 100 coverage looks for companies whose growth came from a specific, describable decision, not luck or timing alone. SupplementMe is an early-stage, unproven case next to names like Notion in this same series, and readers should weigh it accordingly. But the decision to stay small and consistent, rather than expand the catalog for its own sake, is real and worth naming.

See the current range at supplementme.co.uk.